Immune-activating pulsed electric field tumor ablation
This technology uses precisely tuned electrical pulses to kill cancer or diseased tissue cells in controlled ways, choosing between different types of cell death — such as quiet self-destruction (apoptosis), inflammatory death (pyroptosis), or necrotic death (necroptosis) — based on the pulse parameters selected. By engineering the spatial pattern of these different death mechanisms within a tumor, clinicians can deliberately trigger or suppress immune responses in targeted areas. The system includes both treatment planning tools and delivery hardware to execute these tailored electrical protocols. The goal is to make tumor ablation not just destructive but immunologically strategic, potentially priming the immune system to attack remaining cancer cells.
What you could build
A software-guided pulsed electric field ablation system that oncologists or interventional radiologists use to plan and deliver tumor treatments optimized for both local destruction and immune activation — sold to cancer centers and hospitals as an upgrade to or replacement for existing irreversible electroporation platforms.
Who in Virginia should care
Inova Health System, VCU Massey Cancer Center, and UVA's NCI-designated cancer center are plausible early clinical partners; Virginia-based medtech and defense-adjacent life science companies could be licensing targets.
Readiness: Concept
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- Rafael V. Davalos, Kenneth N. Aycock, Nastaran Alinezhadbalalami, Irving Coy Allen
- Filed
- Patent pending — filed September 11, 2024
- Status
- Application
- Publication number
- US20250205481A1
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology.
Prosim summaries are generated from public patent text and are not legal advice.